Out-licensing: Animal Health & Immune Related Disorders

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..3 of 3 - per page
Order by

Bacterial spores for use as an adjuvant

A novel adjuvant technology for use in vaccines and in antibody production that gives excellent immune responses with low manufacturing costs, and can be administered by a variety of routes More

Use of Biological Surfactant as Anti-flammatory Agent and Tissue Preservative Solution

Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More

ELECTRON-VOLT ENERGY RADIATOR

In order to, to achieve the most active action of body energy, it is known that pH of water-containing blood should be maintained at an alkaline of 7.35 to 7.45. More

Displaying 1..3 of 3 - per page
Order by

Your selection

Industry sector: Animal health del
Therapeutic target: Immune related disorders del

Browse By

Industry sector: Diagnostic; Equipment supplies; General supplies; Health & Hygiene; Medical device; Nutrition; Petcare; Pharmaceutical
Therapeutic target: Adoptive immunotherapy; Amyloidosis; Autoimmune disease (non-specific); Chronic fatigue syndrome; Chronic granulomatous disease; Chronic immunosuppression; Gout; Graft versus host disease; HIV/AIDS; Immune disorder (non-specific); Immune thrombocytopenic purpura; Immunomodulation; Immunostimulation; Immunosuppression; Lupus erythematosis; Myalgic encephalomyelitis; Myasthenia gravis; Neoplastic disease; Organ transplant rejection; Rheumatoid arthritis; Servere combined immunodeficency; Sjogren's syndrome; Systemic sclerosis; Transplant rejection; Xenotransplantation
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us